Skip to content
Tuesday, November 10, 2026
Brit Lounge Hub

Users Coming Off Slimming Injections Gain Back Weight Four Times Faster Compared to People Using Diet and Exercise

Illustration of medical syringe and scale
Weight management often requires long-term strategies.

Fresh analysis indicates that individuals who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens.

Research printed in a leading medical journal points out that while overweight people frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month once they quit.

"People using these drugs must be informed of the potential of fast rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to starting mass within about 18 months.

Comparing Therapies

The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the results of these new drugs with older methods.

The team note that people who shed pounds through lifestyle changes alone usually experience a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

Understanding the Fast Rebound

Nutrition scientists propose the mode of action of the injections accounts for the heightened weight return.

These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating much more probable."

A Lifelong Issue?

Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Many experts contend that, considering the significant potential of weight regain, the treatment should be considered life-long.

This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," akin to managing diseases like high blood pressure.

Patient Testimonies

Individuals who have come off the medication describe a sudden resurgence of appetite.

"It was like a switch activating and you're instantly ravenous," said an individual.

This difficulty is compounded if patients have not developed sustainable dietary or behavioural changes during therapy.

Widespread Adoption

Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.

  • Use is more common among females than males.
  • The middle-aged demographic shows the highest usage rates.
  • Many access the medications through private healthcare rather than public health services.

Finally, clinicians caution that while GLP-1 drugs are potent tools for weight loss, they are not a magic fix and lasting health benefits likely depends on integrated lifestyle changes.

KS
About the author

Kevin Simon

Alex is a freelance writer and UK culture enthusiast with a passion for exploring hidden gems across Britain.

Brit Lounge Hub

Type to search articles.